Maybe we read different articles.I read: "(CCR) was struggling to get Wonawinta to a cash-positive operating basis" and its got debt to repay.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025